Logo
Search
Login
Sign Up

Archive

Something Is Happening In Your Body Right Now. You Cannot Feel It Yet.

Mar 18, 2026

Why age-related muscle decline may become one of the most important longevity investment themes of the next decade, and how I think about Dual ROI before the market catches up.

Read More

The 2026 Epigenetic Reprogramming Watchlist: 5 Companies Working To Reset Cellular Age

Mar 17, 2026

Read More

Big Pharma Has $236 Billion Disappearing by 2030. Let's Look At What They Might Be Looking For.

Mar 16, 2026

I Learned This From Selling Part Of My Company. Build What The Buyer Already Needs. Then Overlap It With What May Keep Us Alive.

Read More

Start With The End in Mind: How Big Pharma Actually Decides Which Biotech Companies to Acquire

Mar 11, 2026

I've watched dozens of companies in my 411-company longevity universe get acquired. A pattern kept repeating. Then I remembered selling part of CuraDebt - and realized biotech M&A works exactly the same way.

Read More

The Muscle Problem Nobody Is Talking About

Mar 9, 2026

Sarcopenia, The Science Of Saving Your Strength, And The Companies I Am Watching Right Now

Read More

The 2026 Big Pharma Shopping List

Mar 5, 2026

Where I See The Smart Money Moving - And Why

Read More

Retroactive Analysis: Applying The 25-Gate Framework To 10 Years Of Longevity Biotech (Hypothetical)

Mar 3, 2026

~4.2x hypothetical return. ~$8.0 million in paper gains. Two losses. 411 biotech companies reviewed. 10 years.

Read More

I Was Swimming In Brown Ocean Water In Santa Marta When It Hit Me.

Mar 2, 2026

The longevity intervention that costs nothing, takes five minutes, and has harder data behind it than half the supplements in my cabinet (or companies I'm evaluating).

Read More

I Watched Prometheus Last Night. The Cryopods Almost Aren't Fiction Anymore.

Feb 27, 2026

Why cryopreservation forced me to add a whole new classification to the EverLife Capital framework, and what that means for a healthy 45-year-old targeting 120+.

Read More

Longevity Escape Velocity: The Timeline Nobody Agrees On, What Each Expert Is Actually Doing About It, And Why It Matters To You

Feb 25, 2026

I want to have this conversation with you the way I'd have it over coffee. No hype. No "scientists hate this one trick." Just an honest look at what the smartest people working on aging actually believe, where they disagree, what they're personally doing to bridge the gap, and what it means for people like you and me who are trying to figure out how to plan the next 30, 50, or maybe 80 years of our lives.

Read More
Load more

Everlife Capital

I research longevity biotechs and early-stage companies focusing on healthspan potential and financial metrics to solve the problem of aging (for informational purposes only; not investment or medical advice).

© 2026 Everlife Capital.
Report abusePrivacy policyTerms of use
beehiivPowered by beehiiv